Hydralazine Administration for Severe Hypertension
Do not use hydralazine as a continuous infusion—administer only as intermittent IV bolus doses, starting with 5 mg IV given slowly over 5 minutes, repeated every 20-30 minutes as needed (maximum 25 mg per episode), with blood pressure monitoring every 5-10 minutes until stable. 1, 2, 3
Critical Administration Protocol
Initial Dosing
- Start with 5 mg IV bolus given slowly over 5 minutes 2
- Repeat doses of 10 mg IV every 20-30 minutes if blood pressure remains elevated 1, 2
- Maximum cumulative dose is 25 mg per treatment episode 2
- The FDA label indicates 20-40 mg as the usual dose range, but obstetrical guidelines favor the more conservative 5-10 mg approach 3, 1
Why Bolus Only, Never Continuous Infusion
- Continuous hydralazine infusion causes rapid, uncontrolled blood pressure decline and resulted in fetal distress requiring cesarean delivery in 5 of 7 patients in one study 4
- Bolus dosing is significantly more effective, achieving blood pressure control in 65 minutes versus 186 minutes with continuous drip 5
- Bolus dosing requires lower total doses (6.68 mg vs 20.07 mg) without causing overshoot hypotension 5
Monitoring Requirements
Blood Pressure Monitoring
- Check blood pressure every 5-10 minutes until stable, then every 15 minutes 2
- Blood pressure typically begins to decrease within 10-30 minutes after administration 6
- Average maximal decrease occurs in 10-80 minutes 3
- Duration of action is 2-4 hours 1, 6
Safety Parameters
- Hold or reduce hydralazine if diastolic BP falls below 80 mmHg to prevent maternal hypoperfusion 2, 6
- In high-risk patients (diabetes, age >60, coronary artery disease with heart failure), avoid diastolic BP below 60 mmHg 6
- For obstetrical patients, continuous fetal heart rate monitoring (cardiotocography) is essential 2
Expected Response and Adverse Effects
Hemodynamic Effects
- Mean arterial pressure falls by approximately 12 mmHg after the first bolus, 9 mmHg after the second, and 5 mmHg after the third 7
- Blood pressure control is achieved with bolus therapy alone in 89% of cases when protocol is followed 7
Common Adverse Effects
- Reflex tachycardia and palpitations occur significantly more often with hydralazine than labetalol 1, 8
- Headache, flushing, and vomiting are common 1
- Sodium and water retention may occur 6
- Maternal hypotension is possible but uncommon (2 of 100 patients in one trial) 8
Clinical Context and Limitations
When to Use Hydralazine
- Hydralazine is specifically indicated for hypertensive emergencies in eclampsia 1
- The International Society for the Study of Hypertension in Pregnancy considers it acceptable but not preferred as first-line for acute severe hypertension in pregnancy 2
- Treatment should be initiated within 60 minutes of severe hypertension onset 1
Why Hydralazine Is Less Desirable
- The American Heart Association notes that IV hydralazine has unpredictable response and prolonged duration of action, making it less desirable as first-line in most patients 1
- The European Society of Cardiology recommends more predictable IV agents with shorter half-lives (nicardipine, labetalol, clevidipine) for hypertensive emergencies 2, 6
Practical Considerations
Preparation and Administration
- Use immediately after the vial is opened 3
- Do not add to infusion solutions 3
- May discolor upon contact with metal; discard discolored solutions 3
- Inspect visually for particulate matter before administration 3
Timing of Repeat Doses
- Wait the full 20-30 minutes between doses to assess response 1, 2
- If hydralazine has already been given, wait 2-4 hours to assess full effect before additional treatment episodes 6
- Most patients can be transferred to oral hydralazine within 24-48 hours 3